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Genome-wide Association (GWA) studies have become a widely used method for analyzing genetic data. It is useful in detecting associations that may exist between particular
alleles and diseases of interest. This thesis investigates the dataset provided from problem 1
of the Genetic Analysis Workshop 16 (GAW 16). The dataset consists of GWA data from the
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rheumatoid arthritis. Moreover, this thesis also attempts to address the question of whether
the one-sided alternative hypothesis that the minor allele is positively associated with the
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with the disease is appropriate, or put another way, the question of whether examining both
alternative hypotheses yield more information.
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Chapter 1
INTRODUCTION

1.1 Genome-wide Association (GWA) Studies
There has been a long history, dating back to 1985, behind decoding the human genome
and its potential uses. The Human Genome Project which spanned over 20 years, essentially
sequenced the human genome and allowed researchers to study what all humans have in
common (Roberts, 2001). In addition to the information gained from the Human Genome
Project, the results released by the International HapMap Consortium (2003) further advanced our understanding of the human DNA by studying the variability of the DNA in
several world populations.
There are many exciting successes in this area. For example, Risch and Meringkan (1996)
and WTCCC (2007) list several diseases such as Huntington's disease and Alzheimer's disease
in which researchers have found genetic basis. However, Risch and Meringkan (1996) also
indicated that there had not been many successes in more complex diseases, due to the
modest association of some genes to these diseases. They also suggested that the method of
linkage analysis used for detection has low power in nding linkages between diseases and
genes.

Instead, they showed that GWA studies have much higher power and can detect

associations for the more complex diseases.
The detection of strategically selected markers called Single Nucleotide Polymorphisms
(SNPs), play a vital role in GWA studies.

SNPs are essentially variations in the DNA

sequence of chromosomes. According to International HapMap Consortium (2003), a section
of DNA in a chromosome region will have a sequence of bases consisting of A, T, C, or G.
Whenever these sequences vary across the regions, they are referred to as SNPs. On average,
these variations in the chromosome occur at a rate of one variant per 1,000 bases as reported
by Wang

et al.

(1998). It was also estimated that about 10 million SNPs account for about

90% of the variation in the human population, and the other 10% results from rare variants
in the population (Kruglyak and Nickerson, 2001).

However, according to Gabriel

et al.
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(2002) and Carlson (2003) most of these variations can be studied by genotyping 200,000 to
1,000,000 tag SNPs across the human genome.
In order to conduct a GWA study, researchers take samples of DNA from a group of
people with the disease of interest, and samples of DNA from a control group without the
disease. These samples are then tested for the presence of SNPs that can highlight genetic
abnormalities. If it is found that these abnormalities are signicantly present in individuals
with the disease relative to those without the disease, then those mutations can be considered
as being associated with an increased risk of the disease.
GWA studies have already proven to have some successes. As noted in WTCCC (2007),
these studies have been able to nd signicant associations between specic genetic mutations and certain diseases such as type-II diabetes, Parkinson's disease and Crohn's disease.
However, other more complex diseases, such as rheumatoid arthritis, still hold a challenge
for researchers.

1.2 NARAC Dataset
The dataset in problem 1 of the Genetic Analysis Workshop 16 (GAW 16) is part of the
dataset used by Plenge

et al.

(2007), in which a GWA study was performed on cases, from

North America and Sweden, with anti-CCP positive rheumatoid arthritis.

The GAW 16

dataset is based on the data from North America. After removing duplicated and contaminated samples, this dataset consists of 868 cases and 1,194 controls and contains 545,080
SNPs.

Actually, the initial North American cases were taken from several rheumatology

clinics that make up the NARAC. The cases were randomly drawn from these clinics and
the patients were self-identied as having white ancestry and they are matched with control
subjects according to similar self-identied ethnic background.

1.3 Challenges for Statistical Methods
GWA studies have been made possible due to the improvement of technology. For example, the WTCCC used the Aymetrix GeneChip 500K Mapping Array Set that allowed it
the ability to study 7 diseases in approximately 2,000 cases and 3,000 controls. As pointed
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out by Gabriel

et al.

(2002), the variations in the human population can be studied by geno-

typing 200,000 to 1,000,000 tag SNPs across the genome. While the technology has made it
possible to study associations between diseases and SNPs, it has highlighted some statistical
challenges in terms of analyzing such large datasets that has plagued the statistics for years.
One issue is the curse of high dimensionality (Hastie, Tibshirani and Friedman, 2009).
This problem occurs when the number of variables are much larger than the sample size.
Liang and Kelemen (2008) classied the statistical methods used to address high dimensionality problems into three groups: ltering methods, wrapping methods and embedded
methods. The ltering methods are the most popular, because they are convenient and fast.
When ltering methods are used to address high dimensionality problems, the next big
problem created is the problem of multiple testing. Hypothesis testing is used in GWA studies
to determine which SNPs are most signicantly associated with the disease of interest. Each
SNP that is analyzed constitutes one hypothesis test. In traditional hypothesis testing, the
signicant level is often set at 5%.

However, as shown in the table below as the number

of SNPs tested increases, the number of SNPs falsely claimed to be signicant increases,
provided that all the SNPs are non-signicant.

Table 1.1: Increase in False Positive (α

= 5%)

Number of SNPs Tested

False Positive Incidence

100

5

10,000

500

500,000

25,000

Note: Assume that all the SNPs are non-signicant

Tons of methods have been proposed to combat the problem of multiple testing, as discussed by Hastie

et al. (2009).

According to Lee (2004), the Sequentially Rejective Bonferroni

(SRB) method introduced by Holm (1979), uses an application of Bonferroni correction to
ordered

p-values.

The False Discovery Rate (FDR) method proposed by Benjamini and

Hochberg (1995) is similar to the SRB method in that it uses the ordering of

p-values.

The
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FDR method adjusts these

p-values

as a proportion of the rank of the

p-value

to the total

number of hypothesis tests. These two methods are discussed further in this thesis.

1.4 Armitage Trend Test
One of the disadvantages of the case-control GWA studies is that they are prone to a
number of biases including population stratication, as pointed out by Pearson and Manolio
(2008).

Despite the debate on the importance of considering confounding due to popula-

tion stratication in GWA studies using case-control designs, Thomas and Witte (2002) and
Wacholder

et al.

(2002), the Armitage's trend tests can correct for population stratication

to some extent, as suggested by Armitage (1955), Sasieni (1997) and Schaid and Jacobsen
(1999). Some other methods were also developed for the same purpose, based on the Armitage's trend test, such as the genomic control approach discussed by Devlin and Roeder
(1999) and Reich and Goldstein (2001).
However, there is still a question as to whether the one-sided or the two-sided alternative
hypothesis is appropriate, or put another way, whether or not examining both the onesided and the two-sided alternative hypotheses can give more information. The dataset for
problem 1 of GAW 16 provides us with a chance to address this question, because it is a part
of a combined sample from the NARAC and the Swedish Epidemiological Investigation of
Rheumatoid Arthritis (EIRA). The results from the combined sample is used as a reference.

1.5 Organization of Thesis
The remainder of this thesis is organized as follows. Chapter two provides an overview
of the three classical methods, dierence of proportions, relative risk and odds ratio, used to
analyze case-control data. Chapter three presents the theory behind the Armitage's trend
test for both the one-sided and the two-sided alternative hypotheses as well as the motivation
for its use in this thesis. Chapter four discusses the SRB method and the FDR method, and
their use in nding a threshold to determine the signicant SNPs. Chapter ve compares
the results of the one-sided and the two-sided alternatives when using the Armitage's trend
test and the three classical methods. Chapter six presents some conclusions and discussion.
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Chapter 2
THREE CLASSICAL METHODS

2.1 Notation
The response variable in a GWA study is the status of the disease of interest, either
diseased or non-diseased. The explanatory variable at a SNP is the genotype: AA, Aa or
aa. The data at a SNP are shown in a

2×3

contingency table, as displayed in Table 2.1.

Throughout the thesis, denote the major allele as A", and the minor allele as a". Here the
minor allele is the one with smaller frequency.

Table 2.1: Genotype Distribution at a SNP
AA

Aa

aa

Total

Control

n10
n00

n11
n01

n12
n02

Total

N+0

N+1

N+2

N1
N0
N

Case

In Table 2.1,

N1

and

group respectively, and

N0

denote the numbers of subjects in the case group and the control

N+0 , N+1 and N+2 denote the numbers of the subjects with genotypes

AA, Aa and aa respectively. Let

n10 , n11

and

group and

n12

N

denote the total numbers of subjects in the study. Let

denote the numbers of subjects with genotypes AA, Aa and aa in the case

n00 , n01

and

n02

the corresponding numbers in the control group.

At any SNP, each subject has two alleles, a major allele and a minor allele. By counting
the frequency of the minor allele a" and the major allele A", we can convert Table 2.1 to
a

2×2

contingency table, as displayed in Table 2.2.

Table 2.2: Allele Distribution at a SNP

Case
Control
Total

a"

A"

Total

ñ11 = 2n12 + n11
ñ01 = 2n02 + n01
e
N+1 = 2N+2 + N+1

ñ10 = 2n10 + n11
ñ00 = 2n00 + n01
e
N+0 = 2N+0 + N+1

e1 = 2N1
N
e0 = 2N0
N
e = 2N
N
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In Table 2.2,

e1
N

and

group respectively, and
the dataset. Let

e
N

e0
N

e+1
N

denote the numbers of alleles in the case group and the control
and

e+0
N

denote the numbers of the minor and major alleles in

denote the total number of alleles in the study. Let

the numbers of minor and major alleles in the case group and
minor and major alleles in the control group. Let
the minor allele a" in the case group, and

P0

P1

ñ01

and

ñ11

and

ñ10

ñ00

the numbers of

denote

denote the population proportion of

denote the population proportion of the minor

allele a" in the control group. Dene the sample proportion of the minor allele in the case
group as
as

e1
p
1 = n
e11 /N

e0 .
p
0 = n
e01 /N

and the sample proportion of the minor allele in the control group

Agresti, (2007) describes three classical methods, dierence of proportions,

relative risk and odds ratio to analyze

2×2

tables, such as Table 2.2.

2.2 Dierence of Proportions
Because

D = P1 − P0

compares the population proportion of the minor alleles in the case

group with that in the control group, if the dierence of proportions is zero, then there is no
association between the SNP and the risk of disease. If

P1 > P0 ,

then there exists a positive

association between the minor allele and the risk of disease.
The dierence of sample proportions

dˆ = p̂1 − p̂0

pooled sample proportion of the minor allele.

estimates

D.

Let

e+1 /N
e
p̂ = N

Under the null hypothesis that there is no

association between the SNP and the risk of disease, the estimated standard error of

s
ˆ =
SE(d)

To test the H0 :

P1 = P0 ,

be the

p
(1 − p
)

e
N

.

dˆ is,

(2.1)

the test statistic is

Z1 =

p
1 − p
0

ˆ
SE(d)

,

which asymptotically follows the standard normal distribution under the H0 .

(2.2)
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For the one-sided alternative hypotheses that the minor allele is positively associated
with the disease of interest, that is

P1 > P0 ,

the

p-value

is Prob(N (0, 1)

≥ Zobs
1 ).

For

the two-sided alternative hypotheses that the genotypes are associated with the disease of
interest, that is

P1 6= P0 ,

the test based on

Z1

is equivalent to the test based on

asymptotically follows a chi-squared distribution with one degree of freedom,

2
is Prob(χ1

χ21 .

Z12 ,

The

which

p-value

≥ Z12obs ).

2.3 Relative Risk
The method based on dierence of proportions is not eective when the proportions are
near 0 (Agresti, 2007). The method of relative risk can solve this problem. The relative risk
is dened as

ρ = 1,

ρ = P1 /P0 ,

which can be estimated by the sample relative risk of

ρ̂ = p1 /p0 .

then there is no association between the SNP and the risk of disease. If

ρ > 1,

If

then

there exists a positive association between the minor allele and the risk of disease.
To avoid skewness in the asymptotic distribution of
estimated standard error of

log ρ̂

SE(log ρ̂) =

P1 = P0

the

log ρ̂

is considered.

The

is (Agresti, 2007)

s

To test the H0 :

ρ̂,

(1 − p1 ) (1 − p0 )
+
.
e1 p1
e0 p0
N
N

(2.3)

the test statistic is

Z2 =

log pp1
0

SE(log ρ̂)

,

(2.4)

which asymptotically follows the standard normal distribution under the H0 .
For the one-sided alternative hypotheses that the minor allele is positively associated with
the disease of interest, that is

P1 > P0 , the p-value is Prob(N (0, 1) ≥ Zobs
2 ).

For the two-sided

alternative that the genotypes are associated with the disease of interest, that is
the test based on

Z2

is equivalent to the test based on

chi-squared distribution with one degree of freedom,

χ21 .

Z22 ,

P1 6= P0 ,

which asymptotically follows a

The

p-value

2
is Prob(χ1

≥ Z22obs ).
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2.4 Odds Ratio
Another method used is the odds ratio test statistic which is based on the ratio of the
odds of the minor allele in the case group with that in the control group. The odds of the
minor allele in the case group is dened as
allele in the control group is dened as
as

θ=

odds1 = P1 /(1 − P1 )

odds2 = P0 /(1 − P0 ).

and the odds of the minor

The odds ratio can be dened

P1
/ P0 , which can be estimated by the sample odds ratio
1−P1 1−P0

θ̂ =

p̂1
/ p̂0 . If
1−p̂1 1−p̂0

then there is no association between the SNP and the risk of the disease.

If

θ = 1,

θ > 1,

then

there exists a positive association between the minor allele and risk of the disease.
To avoid skewness in asymptotic distribution of
standard error of the

log θ̂

SE(log θ̂) =

P1 = P0

the

log θ̂

is considered. The estimated

is (Agresti, 2007)

r

To test the H0 :

θ̂,

1
1
1
1
+
+
+
.
n
e11 n
e10 n
e01 n
e00

(2.5)

the test statistic is,

Z3 =

log θ̂
SE(log θ̂)

,

(2.6)

which asymptotically follows the standard normal distribution under the H0 .
For the one-sided alternative hypotheses that the minor allele is positively associated
with the disease of interest, that is

P1 > P0 ,

the

p-value

is Prob(N (0, 1)

≥ Zobs
3 ).

For

the two-sided alternative hypotheses that the genotypes are associated with the disease of
interest, that is

P1 6= P0 ,

the test based on

Z3

is equivalent to the test based on

asymptotically follows a chi-squared distribution with one degree of freedom,

2
is Prob(χ1

≥ Z32obs ).

χ21 .

Z32 ,

The

which

p-value
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Chapter 3
ARMITAGE TREND TEST

3.1 Population Stratication
Case-control designs are useful in analyzing GWA studies to answer the question of which
SNPs are most signicantly associated with an increase risk of disease. However, the main
drawback of case-control studies is that they are prone to population stratication.
Population stratication is a form of confounding that can occur specically in genetics
studies, such as GWA studies. This type of confounding occurs when two or more subgroups
of the population under study display a large variation in the allele frequencies of the gene
being investigated. These subgroups also dier from the rest of the population in the risk of
disease. There are many causes of population stratication. One possible cause is migration.
The migrated group of people maybe susceptible to a particular disease and has become part
of a larger population (Thomas and Witte, 2002). In this situation, a case-control study will
detect a false association between the population and the disease of interest, that is really
being caused by the association between the migrated subgroup and the disease of interest.
There are several examples of population stratication that highlight the seriousness of
the problem, and the adverse eects it can have on the results of a study, Thomas and Witte
(2002). One of those examples involves a genetic association study that suggested an inverse

3,5,13,14
association between variants in the immunoglobulin haplotype Gm
and non-insulindependent diabetes mellitus in members of the Gila River Indian Community. After further
investigation of this association, it was determined that the inverse association was due to
the Caucasian heritage among the community.

In fact, there was an association between

3,5,13,14
heritage and Gm
and between Caucasian heritage and risk of the specic diabetes
mellitus. Once the data was corrected for heritage, the results no longer reected the inverse
association.
Figure 3.1 was presented in Wacholder

et al.

(2002) to explain population stratication.

Case-control studies can consist of participants with several unknown backgrounds, such as
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Confounding
Exposure of
Interest

True Risk
Factor

Disease

Population Stratification

Ethnicity

Genotype of
Interest

True Risk
Factor

Disease

Fig: Classical confounding and population stratification. In population stratification, the
frequency of an unmeasured risk factor for disease differs by ethnicity. Broken lines with
arrow indicate an association that is potentially confounded by the true risk factor. Solid
unidirectional arrows indicate the direction of causal relationship. Solid bidirectional
arrows indicate a correlation that may or may not be causal. Reprinted from Journal of
the National Cancer Institute.

Figure 3.1: Confounding and Population Stratication

ethnicity. When these participants are pooled together in the study, an association may be
observed between a genetic variant and the disease of interest. However, if the participants
are broken up based on their background, such as ethnicity, then the observed association
between a genetic variant and the disease of interest may no longer exist.

3.2 Armitage Trend Test
This disadvantage is overcomed, to some extent, by applying the Armitage's trend test,
as suggested by Armitage (1955), Sasieni (1997), and Schaid and Jacobsen (1999). Sasieni
(1997) discusses the use of three dierent approaches for the analysis of genetic case-control
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data.

The rst approach dierentiates the subjects into three categories, those in which

the allele of interest is recessive, those in which the allele of interest is co-dominant, an
heterozyous allele, and those in which the allele of interest is dominant, an homozygous
allele. This approach uses a standard

2×3

contingency table, as in Table 2.1. The second

approach is to combine the heterozygous and homozygous separate from the subjects without
the allele of interest.

The third approach is to consider the allele frequency for the cases

and controls, which in eect doubles the sample size. These last two approaches use a
contingency table.

2×2

Sasieni (1997) concluded that an analysis based on treating alleles as

individual entities is valid only when the Hardy-Weinberg equilibrium holds. As a result,
he warns against this allelic based analysis and recommends that genetic case-control data
be analyzed using genotype approach. Below is the generic contingency table from Sasieni
(1997), denoting the major allele as A", and the minor allele as a". Table 3.1 is identical
to Table 2.1, except for the addition of the three scoring systems in Table 3.1.

Table 3.1: Scores for Armitage's Trend Test

Case
Control
Total
Score

In order to analyze such

2×3

AA

Aa

aa

Total

n10
n00

n11
n01

n12
n02

N+0
x0

N+1
x1

N+2
x2

N1
N0
N

contingency tables, a test statistic based on scores was

developed to determine whether there is a linear trend in proportions (Armitage, 1955;
Sasieni, 1997; and Schaid and Jacobsen, 1999). Let

j th

column of the contingency table,

XA2

j =0,

xj

denote the score associated with the

1, 2. The Armitage's trend test statistic is

N (N Σn1j xj − N1 ΣN+j xj )2
=
.
N1 N0 [N ΣN+j x2j − (ΣN+j xj )2 ]

(3.1)

This statistics has an approximate chi-square distribution with one degree of freedom
under the null hypothesis. When considering the two-sided alternative hypothesis that the
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genotypes at a SNP are associated with the disease of interest, this statistic can be employed.
An important part of this statistic is the choice of the scoring system. According Armitage
(1955), while the score does not aect the validity of the test, it does aect the power of the
test. If there is no prior information or known relationship between the columns, it can be
dicult to determine a scoring system. However, in analyzing the contingency table above,
there are three common scoring systems used.
of the following: (1) co-dominant score:

x0 = 0, x1 = 1

and

x2 = 1;

The scoring system can be chosen as one

x0 = 0, x1 = 1,

(3) recessive score:

and

x0 = 0, x1 = 0,

x2 = 2;
and

(2) dominant score:

x2 = 1.

Since the disease

can be consider rare, the minor allele can be assumed to be of interest in terms of increased
risk of the occurrence of the disease. So the system is in favor of this minor allele.

3.3 One-Sided and Two-Sided Alternative Hypotheses
The Armitage's trend test statistic can also be adjusted for the one-sided alternative
hypotheses. There are two one-sided alternatives, (i) the alternative that the minor allele is
positively associated with the disease of interest; (ii) the alternative that the major allele is
positively associated with the disease of interest. As mentioned above, the disease can be
considered to be rare, so that the rst alternative hypothesis is more logical. However, if
no prior information is known, both alternative hypotheses would have to be considered. So
Armitage's trend test for the one sided alternative hypotheses is,

√
N (N Σn1j xj − N1 ΣN+j xj )
.
ZA = q
N1 N0 [N ΣN+j x2j − (ΣN+j xj )2 ]

(3.2)

Under the null hypothesis, this statistic is approximately distributed with a

N (0, 1).

The

same scoring systems described above can be used.
If the one-sided alternative hypotheses (i) is considered, the

p-value

= Prob(N (0, 1)

≥

ZAobs ); if the one-sided alternative hypotheses (ii) is considered, the p-value = Prob(N (0, 1) ≤
ZAobs );

if two-sided alternative hypotheses is considered, the

p-value

2
= Prob(χ1

≥ XAobs ).
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Chapter 4
FINDING THRESHOLDS

4.1 Notation
A statistical challenge in dealing with the data from a GWA study is that the number of
variables is much larger than the sample size. The problem is so-called multiple comparison.
In the GWA study, each SNP to be analyzed constitutes one hypothesis test. When testing
hundred thousands of hypotheses simultaneously, it is important to determine a threshold
for selecting the most signicant SNPs. While tons of methods have been proposed to deal
with this problem, this thesis reviews and compares two approaches: the SRB method and
the FDR method.
Some notations for these two methods are dened as follows.

n

null hypotheses

denoted by

H1 , H2 , H3 , · · ·,

K1 , K2 , K3 , · · ·,

Y1 , Y2 , Y3 , · · ·,

and

Yn .

and

Let the

n

and

Kn .

Hn .

Assume that there are

Their corresponding alternative hypotheses are

To test for these null hypotheses, test statistics are

critical regions be

C1 , C2 , C3 , · · ·,

and

Cn .

Particularly, in

this thesis, the test for each null hypotheses could be one of the three classical methods and
the Armitage trend tests with the three dierence scores.

4.2 Sequentially Rejective Bonferroni Method
One approach in dealing with the multiple testing problem is the Sequentially Rejective
Bonferroni (SRB) method. This was proposed by Holm (1979). The method is based on the
Bonferroni test and requires the type-I error to be as small as possible. Philosophically, for
each of these

n

tests, the probability of committing a type-I error is less than or equal to

a small predetermined value

α.

Rejecting a null hypothesis constitutes making a discovery,

that the alternative hypotheses is statistically signicant.
Now let the corresponding
be

P1 , P2 , P3 , · · ·,

are ordered

and

Pn ,

p-values generated from the test statistics, Y1 , Y2 , Y3 , ···,

where

Pk = αk (Yk ),

P (1) ≤ P (2) ≤ P (3) ≤ · · · ≤ P (n) ,

where

k =1,

2,

· · ·, n.

When these

and

Yn ,

p-values

along with their corresponding hypotheses,

H (1) ≤ H (2) ≤ H (3) ≤ · · · ≤ H (n) , the most signicant ones would have the smallest p-values.
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As shown in Table 1.1, the number of false positives increases as the number of null hypotheses tested increases. The SRB method attempts to solve this multiple testing problem

α,

by adjusting the signicant level

p-values.

Specically, these

for each hypotheses tested, before comparing it with the

p-values

are compared to corresponding levels denoted by

α α
α
,
, · · ·, .
n n−1
1

(4.1)

The hypotheses are rejected until no other rejections are possible. Since the most important
hypotheses would have the smallest

α/(n − i + 1),

where

i

= 1, 2, 3,

p-values,

· · ·, n.

they are compared with the smallest level of

The least important hypotheses are compared with

increasingly larger levels.

4.3 False Discovery Rate Controlling Method
Another approach to combating the multiple testing problem that arises in GWA studies
comes from an idea proposed by Benjamini and Hochberg (1994), referred to as False Discovery Rate (FDR). They noted that the classical approaches despite their uses in industries
are less likely used in genetic.
Many multiple testing procedures, such as the SRB method, are based on controlling the
type-I error. The FDR method takes a philosophically dierent approach, in that it takes
into account the number of hypotheses that are falsely rejected, that is the number of false
discoveries. As a result, the FDR can be dened as the expected proportion of errors among
the reject hypotheses.

Table 4.1: Number of Errors Committed When Testing

True Null Hypotheses
Non-true Null Hypotheses

n

Null Hypotheses

Declared non-signicant

Declared signicant

Total

U
T
n−R

V
S
R

n0
n − n0
n

The FDR method considers testing simultaneously

n null hypotheses of which n0 are true.

The situation is summarized in Table 4.1. Benjamini and Hochberg (1994) suggested that
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the unknown random variable

Q = V /R,

can be used to represent the proportion of errors

committed by falsely rejecting the null hypotheses. This is the proportion of the rejected
null hypotheses which are erroneously rejected. Let the FDR be represented by
the expectation of

Q.

Qc

which is

Then we have

V
Qc = E(Q) = E( ).
R

(4.2)

The FDR method is conducted as follows. Consider testing
corresponding

p-values P1 , P2 , · · ·,

P (3) ≤ · · · ≤ P (n) ,

and

Pn .

When these

H1 , H2 , · · ·,

p-values

p-values, and denote by H(i)

P(i) ≤

H(i) , i = 1, 2, · · ·, k .

are ordered

based on the

P (1) ≤ P (2) ≤

Let

P(1) ≤ P(2) ≤ · · · ≤ P(n)

the null hypothesis corresponding to

the following Bonferroni-type multiple testing procedure: Let

then reject all

Hn

H (1) ≤ H (2) ≤ H (3) ≤ · · · ≤

along with their corresponding hypotheses,

H (n) , the most signicant ones would have the smallest p-values.
be the ordered

and

k

be the largest

i ∗
q ;
n

i

P(i) .

Dene

for which

(4.3)

As stated by Theorem I in Benjamini and Hochberg

(1994), for independent test statistics and for any conguration of false null hypotheses, the
above procedure controls the FDR at

q∗.

4.4 Comparison of SRB method and FDR method
These methods take two philosophically dierent approaches to the multiple comparison
problem. With these two approaches, there is some measure of tradeo that exists between
the type-I and type-II errors.
The SRB method focuses on keeping the type-I error small.
taking the predetermined value of

2), · · ·, 1/1.
icance.

α,

This is accomplished by

and reducing it by a factor of

These adjusted levels are then compared to the

1/n, 1/(n − 1), 1/(n −

p-values

to determine signif-

The FDR method instead focuses on controlling the expected number of falsely

rejected hypotheses,

q∗.

This is accomplished by taking the

q∗

and reducing it by a factor
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of

1/n, 2/n, 3/n, · · ·, n/n.

These adjusted levels are then compared with the

p-values

to

determine signicance.

Comparison of SRB and FDR Methods
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L e v e ls
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0
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Number of SNPs Tested

Figure 4.1: Comparison of Levels from SRB and FDR Methods

Note: Assume there are 100 SNPs to be tested. For SRB method α=0.05. For FDR method q ∗ =0.05.
Figure 4.1 compares these two approaches by looking at the factors that adjust
SRB method and

q∗

for the FDR method. It shows that

1/n, 2/n, 3/n, · · ·, n/n

α

for the

1/n, 1/(n − 1), 1/(n − 2), · · ·, 1/1 ≤

at all corresponding levels. This means that the FDR method has a

larger type-I error, and hence more false positives than the SRB method.
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Chapter 5
RESULTS

5.1 Thresholds for NARAC Dataset
The Bonferroni correction is the most popular method for adjusting the type-I error,
It accomplishes this by using

α/n,

where

adjusted value is compared with the

n

α.

is the number of hypotheses to be tested. This

p-values

from the statistical tests.

For the NARAC

− log(α/n).

dataset,

n

α=0.05,

this gives a threshold of 9.17, which will be considered a strict threshold for the

= 545,080. The LOD threshold from the Bonferroni correction is

If

NARAC dataset.
The SRB and FDR methods can also be used to test hundreds of thousands of hypotheses
simultaneously and indicate which SNPs are signicantly associated with the disease of
interest. To illustrate this, the test based on the dierence of proportions and the Armitage's
Trend test with the three types of scores are conducted for each SNP. The tests based on
the relative risk and the odds ratio are not shown here since they yield similar results to
the test based on the dierence of proportions. For each test, all chromosomes are pooled
together and their
using

− log P(i) ,

p-values

where

are arranged in ascending order. The LOD values are calculated

i = 1, 2, · · ·, n

By using the SRB method, if
once

α

and the log is in base 10.

= 0.05 then the SNPs are considered to be signicant

− log P(i) ≥ − log α/(n − i + 1).

Table 5.1 illustrates this procedure for both one-sided

alternative that the minor allele is positively associated with the disease of interest and the
two-sided alternative that the genotypes are associated with the disease of interest using the
test based on the dierence of proportions. For the one-sided alternative, the rst 110 SNPs
in Table 5.1 are considered to be signicant, since at the
time that

− log P(i) < − log α/(n − i + 1).

− log P(i) < − log α/(n − i + 1).

SNP, we observe for the rst

For the two-sided alternative, the rst 267 SNPs

in Table 5.1 are considered to be signicant, since at the
time that

111th

268th

SNP, we observe for the rst
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Similarly, by the FDR method, if the FDR is controlled at

− log P(i) ≥ − log(i/n)q ∗ .

are considered to be signicant once

q ∗ =0.05

then the SNPs

Table 5.2 illustrates this

procedure for both one-sided alternative that the minor allele is positively associated with
the disease of interest and the two-sided alternative that the genotypes are associated with
the disease of interest using the test based on the dierence of proportions.

For the one-

sided alternative, the rst 305 SNPs in Table 5.2 are considered to be signicant, since at the

306th

− log P(i) < − log(i/n)q ∗ .

SNP, we observe for the rst time that

For the two-sided

alternative, the rst 1,571 SNPs in Table 5.2 are considered to be signicant, since at the

1, 572th

SNP, we observe for the rst time that

− log P(i) < − log α/(n − i + 1).

Other tables

using the Armitage's trend tests with the three types of scores are provided in Appendix A.

Table 5.1: SRB Method Applied to All Chromosomes Using Dierence of Proportions
One-Sided Alternative

i

− log P(i)

Two-Sided Alternative

− log

α
n−i+1

i

− log P(i)

α
− log n−i+1

1

15.95458977

7.037490243

1

15.95458977

7.037490243

2

15.95458977

7.037489446

2

15.95458977

7.037489446

3

15.65355977

7.037488649

3

15.95458977

7.037488649

4

15.65355977

7.037487853

4

15.95458977

7.037487853

5

15.65355977

7.037487056

5

15.95458977

7.037487056

·
·
·

·
·
·

·
·
·

·
·
·

·
·
·

·
·
·

106

7.371783044

7.037406576

263

7.117567861

7.037281443

107

7.280601029

7.037405779

264

7.093959244

7.037280646

108

7.251640762

7.037404982

265

7.08718124

7.037279849

109

7.102001717

7.037404185

266

7.056862889

7.037279052

110

7.073791831

7.037403388

267

7.045368703

7.037278255

111

6.925704639

7.037402591

268

7.022062247

7.037277458

5.2 Two-Sided Alternative with SRB and FDR
This thesis attempts to conduct the tests based on the NARAC dataset, and hopes to
produce results similar to those in Plenge

et al.

(2007) based on the NARAC and EIRA

datasets. The results from that paper identify SNPs on chromosome 9 which contain the
common genetic variant at the TRAF1-C5, as being associated with the disease of interest.
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Table 5.2: FDR Method Applied to All Chromosomes Using Dierence of Proportions
One-Sided Alternative

Two-Sided Alternative

i

− log P(i)

− log ni q ∗

i

− log P(i)

− log ni q ∗

1

15.95458977

7.041392685

1

15.95458977

7.037490243

2

15.95458977

6.740362689

2

15.95458977

6.736460247

3

15.65355977

6.56427143

3

15.95458977

6.560368988

4

15.65355977

6.439332694

4

15.95458977

6.435430252

5

15.65355977

6.342422681

5

15.95458977

6.338520239

·
·
·

·
·
·

·
·
·

·
·
·

·
·
·

·
·
·

301

4.574769683

4.56282619

1567

3.846768666

3.842421246

302

4.568560359

4.561385742

1568

3.846747367

3.842144185

303

4.5668634

4.559950057

1569

3.844239762

3.841867299

304

4.564884748

4.558519102

1570

3.843674598

3.841590591

305

4.560209023

4.557092846

1571

3.842915061

3.841314058

306

4.546526523

4.555671259

1572

3.839681445

3.841037701

To this end, this thesis focuses on chromosome 9 in its analysis of results. The results from
the other chromosomes can be analyzed similarly, but are not reported in this thesis. Based
on Tables 5.1 and 5.2 the FDR gives a treshold of about 4, while the SRB gives a threshold
of about 7. The Bonferroni correction yields a strict threshold of 9.17 and the SRB is closer
than the FDR to the Bonferroni correction. So a threshold of 7 is used.
Tables 5.3 and 5.4 show the SRB and FDR methods respectively. These tables are based
on the two-sided alternative hypotheses that the genotypes are associated with the disease
of interest. The threshold from the FDR method suggest that 100 SNPs from chromosome
9 are signicant. The rst 15 of these SNPs are illustrated in Table 5.4. The SRB method
suggest that 12 SNPs are signicant. The SNPs reported in Plenge

et al.

(2007) are marked

by asterisks in both tables.
In Table 5.3, results from Armitage's trend tests, which corrects for population stratication to some extent, are shown in columns

2
2
XA1
, XA2

and

2
XA3
.

These three columns

correspond to the three type of scoring systems. For the SNPs with asterisks,
to be more signicant than

2
XA2

and

2
XA3
.

2
XA1

seems

This suggests that these SNPs are more likely
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to be co-dominant. For the remaining SNPs,

2
XA2

2
XA3

is slightly more signicant than

2
XA1
,

but

is not signicant. This shows that these SNPs are very likely to be recessive. Table 5.4

is similarly analyzed, in that the SNPs with asterisks are co-dominant, while those without
the asterisks are recessive.
Another interesting observation from Table 5.3, is that the SNP rs10985073" does not
appear in this table, even though Plenge

et al.

(2007) has it as being signicant. This can be

explained by the fact that the SRB method, while it has a smaller probability of committing
type-I errors compared to the FDR method, it has a larger probability of committing type-II
errors compared to the FDR. The SRB has a larger probability of having false negatives.
This is the case with SNP rs10985073". It does not show up as being signicant, but if the
results of Plenge

et al.

(2007) can be trusted, it is signicant.

Most important to the goal of this thesis is that the result from the dierence of proportions shown in column
Plenge

et al.

Z12

show that more SNPs are reported to be signicant than in

(2007). The other two classical methods report similar outcomes. The dier-

ence of proportions was used in Plenge

et al.

(2007) to show signicance. The question is

whether these additional SNPs are truly signicant, or are they false positives. This question
is answered partially by looking at the results from the one-sided alternative hypotheses.

5.3 One-Sided Alternative with SRB and FDR
This thesis attempts to determine whether the one-sided alternative hypothesis that the
minor allele is positively associated with the disease of interest or the two-sided alternative
hypothesis that the genotypes at a locus are associated with the disease interest is appropriate. Tables 5.5 and 5.6 illustrates the results of the one-sided alternative hypotheses using
the SBR and FDR methods respectively. Both Tables show that fewer SNPs are signicant
compared to the two-sided alternative.
In Table 5.6 suggest that only 25 SNPs are signicant using the FDR threshold compared to the 100 SNPs under the two-sided alternative. The six SNPs reported in Plenge

et al.

(2007) are marked with asterisks. The FDR threshold shows that 19 other SNPs are
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also signicant. As discussed in Chapter 4, the FDR method has larger type-I error when
compared to the SBR method. The FDR has a larger probability of selecting false positives.
These 19 SNPs are very likely false positives.
The results in Table 5.5 using the SRB threshold are completely consistent with the results reported in Plenge

et al.

(2007). The SRB method has smaller type-I error compared

to the FDR method. It has a smaller probability of selecting SNPs that are false positives.
Moreover, by considering the one-sided alternative, the number of false positive SNPs reported under the two-sided alternative is signicantly reduced. For the NARAC dataset, it
seems more reasonable to consider the one-sided alternative that the minor allele is positively
associated with the disease of interest.
These results are made even more clear by observing Figure 5.1 that shows the graphs the
LOD values of the test based on dierence of proportions and the Armitage's trend test using
the three types of scores. The graphs compare the two-sided and one-sided alternatives. It is
observed that under the two-sided alternative more SNPs appear to be above the threshold
and hence more are signicant, than compared to the one-sided alternative.

This further

supports the result that the one-sided alternative is more appropriate. The graphs for the
other chromosomes are provided in Appendix B.

Table 5.3: Chromosome 9 - Two Sided Alternative Using SRB

2
XA1

2
XA2

2
XA3

SNP

Z12

rs872863

15.65355977

14.77849851

1.514451286

15.10949173

rs12380341

11.61068906

10.01190276

0.357222945

13.45216265

rs7854383

8.848399893

8.349044334

1.426720752

8.425534747

rs11792145

8.583459392

6.530999627

0.035692369

12.24026001

*rs2900180

8.205139225

8.188440621

5.195706388

6.093046561

*rs3761847

7.905145845

7.745195252

5.923341449

5.027178064

*rs881375

7.644376052

7.630402983

4.814960586

5.711575544

*rs1953126

7.558423781

7.532747742

5.048066573

5.443400865

rs11185665

7.541426497

6.479544704

0.325826012

9.681503269

*rs10760130

7.422629646

7.296316207

6.032196468

4.398693388

rs16929545

7.222324725

6.706251792

1.010274200

7.615575785

rs7021867

7.169175803

7.145823736

3.429323902

6.060016234
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Table 5.4: Chromosome 9 - Two-Sided Alternative Using FDR
SNP

Z12

2
XA1

rs872863

15.65355977

14.77849851

1.514451286

15.10949173

rs12380341

11.61068906

10.01190276

0.357222945

13.45216265

rs7854383

8.848399893

8.349044334

1.426720752

8.425534747

rs11792145

8.583459392

6.530999627

0.035692369

12.24026001

*rs2900180

8.205139225

8.188440621

5.195706388

6.093046561

*rs3761847

7.905145845

7.745195252

5.923341449

5.027178064

*rs881375

7.644376052

7.630402983

4.814960586

5.711575544

*rs1953126

7.558423781

7.532747742

5.048066573

5.443400865

2
XA2

2
XA3

rs11185665

7.541426497

6.479544704

0.325826012

9.681503269

*rs10760130

7.422629646

7.296316207

6.032196468

4.398693388

rs16929545

7.222324725

6.706251792

1.0102742

7.615575785

rs7021867

7.169175803

7.145823736

3.429323902

6.060016234

*rs10985073

6.979571033

6.871828281

5.630131282

4.190117723

rs10815605

6.911648334

5.377070055

0.108460003

9.081435534

rs2087358

6.702586771

5.676697464

0.048732253

9.267784016

Table 5.5: Chromosome 9 - One-Sided Alternative Using SRB
SNP

Z

ZA1

ZA2

ZA3

*rs2900180

8.50616922

8.489470624

5.496736384

6.394076556

*rs3761847

8.206175845

8.046225245

6.224371444

5.32820806

*rs881375

7.945406048

7.931432977

5.115990582

6.01260554

*rs1953126

7.859453775

7.833777737

5.349096569

5.744430861

*rs10760130

7.723659641

7.597346203

6.333226464

4.699723384

*rs10985073

7.280601029

7.172858277

5.931161278

4.491147719
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Table 5.6: Chromosome 9 - One-Sided Alternative Using FDR
SNP

Z

ZA1

ZA2

ZA3

*rs2900180

8.50616922

8.489470624

5.496736384

6.394076556

*rs3761847

8.206175845

8.046225245

6.224371444

5.32820806

*rs881375

7.945406048

7.931432977

5.115990582

6.01260554

*rs1953126

7.859453775

7.833777737

5.349096569

5.744430861

*rs10760130

7.723659641

7.597346203

6.333226464

4.699723384

*rs10985073

7.280601029

7.172858277

5.931161278

4.491147719

rs10821376

6.311121125

6.226259449

4.977581247

4.187365559

rs10122120

6.092889305

5.965322782

3.553945037

4.974853751

rs1412224

5.918572721

5.667379507

3.562094393

4.548336867

rs7037866

5.849851994

5.770187608

2.642452562

5.628537838

rs3802400

5.812590713

5.734669784

2.840231366

5.354178503

rs942152

5.705178895

5.680209038

4.033059385

4.121280492

rs540124

5.559100556

5.189371179

3.943581378

3.788547028

rs9409575

5.525573516

5.458565469

2.762855576

4.880818507

rs306772

5.441733507

5.373340922

2.815296589

4.589856973

rs2578240

5.282875011

5.305390553

2.56494468

5.050914524

rs10758875

5.164580164

5.240910111

2.579385278

4.988672234

rs913588

5.062264344

5.064095565

2.628907803

4.821522642

rs2025324

4.92685557

4.767655552

2.977829096

3.936825417

rs3802401

4.779773872

4.783660502

1.846746222

4.449794008

rs965474

4.766941026

4.698495465

4.27441813

2.872064904

rs1468673

4.758838365

4.700002288

2.608394768

4.136229612

rs3897745

4.689205229

4.727279688

1.580076088

4.564260452

rs7022212

4.601264948

4.360589882

2.363891926

3.8173894

rs548348

4.564884748

4.508921901

3.704820517

3.084481137
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Figure 5.1: Chromosome 9 Two Sided and One Sided
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Chapter 6
CONCLUSIONS
This thesis attempts to determine a set of SNPs that are signicantly associated with
rheumatoid arthritis using the NARAC data. In addition, this thesis also attempts to address the question of whether the one-sided alternative hypotheses that the minor allele is
positively associated with the disease of interest or the two-sided alternative hypotheses that
the genotypes are associated with the disease of interest is appropriate. The results from this
thesis are compared with the work from Plenge

et al.

(2007), under the assumption that if

results were trustful based in the combined sample (NARAC and EIRA), then similar results
can be obtained based on a part of the sample (NARAC).
From the analysis in chapter 5, concentrating on the one-sided alternative tends to remove
much of the noise that is present when considering the two-sided alternative.
the similar results as Plenge

et al.

(2007).

This yields

The Armitage Trend test, which controls for

population stratication to some extent, can also be used to determine which SNPs are
likely co-dominant, recessive and dominant.
The SRB and FDR methods are used to deal with the problem of multiple comparisons
in GWA studies. The SRB method, because of a smaller type-I error, seems to work better
than the FDR method. However, a smaller type-I error indicates a larger type-II error and
hence smaller power. The FDR method would have larger power compared with the SRB
method. So care must be taken when deciding which method to use, since there is often a
tradeo between type-I error and power.
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APPENDIX A
METHODS APPLIED TO ALL CHROMOSOMES

30

Table A.1: SRB Method Applied to All Chromosomes Using Armitage Trend Test: Score 1
One-Sided Alternative

Two-Sided Alternative

i

− log P(i)

α
− log n−i+1

7.037490243

1

15.95458977

7.037490243

15.95458977

7.037489446

2

15.95458977

7.037489446

15.95458977

7.037488649

3

15.95458977

7.037488649

4

15.95458977

7.037487853

4

15.95458977

7.037487853

5

15.95458977

7.037487056

5

15.95458977

7.037487056

·
·
·

·
·
·

·
·
·

·
·
·

·
·
·

·
·
·

105

7.29933708

7.037407373

204

7.094042645

7.037328472

106

7.249840288

7.037406576

205

7.081299247

7.037327675

107

7.172858277

7.037405779

206

7.070780584

7.037326878

108

7.168687338

7.037404982

207

7.065220047

7.037326081

109

7.11051051

7.037404185

208

7.037803289

7.037325284

110

6.977747803

7.037403388

209

7.02652442

7.037324487

i

− log P(i)

1

15.95458977

2
3

α
n−i+1

− log

Table A.2: FDR Method Applied to All Chromosomes Using Armitage Trend Test: Score 1
One-Sided Alternative

Two-Sided Alternative

i

− log P(i)

− log ni q ∗

i

− log P(i)

− log ni q ∗

1

15.95458977

7.037490243

1

15.95458977

7.037490243

2

15.95458977

6.736460247

2

15.95458977

6.736460247

3

15.95458977

6.560368988

3

15.95458977

6.560368988

4

15.95458977

6.435430252

4

15.95458977

6.435430252

5

15.95458977

6.338520239

5

15.95458977

6.338520239

·
·
·

·
·
·

·
·
·

·
·
·

·
·
·

·
·
·

281

4.594796099

4.588783923

1339

3.916876178

3.910709666

282

4.590472185

4.587241135

1340

3.914022299

3.910385445

283

4.58912837

4.585703807

1341

3.913043637

3.910061465

284

4.586435957

4.584171903

1342

3.90987487

3.909737727

285

4.58600428

4.582645383

1343

3.909431274

3.90941423

286

4.581096046

4.58112421

1344

3.908970886

3.909090974
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Table A.3: SRB Method Applied to All Chromosomes Using Armitage Trend Test: Score 2
One-Sided Alternative

Two-Sided Alternative

i

− log P(i)

α
− log n−i+1

7.037490243

1

15.95458977

7.037490243

15.65355977

7.037489446

2

15.65355977

7.037489446

3

15.25561977

7.037488649

3

15.47746852

7.037488649

4

15.17643852

7.037487853

4

15.47746852

7.037487853

5

15.10949173

7.037487056

5

15.47746852

7.037487056

·
·
·

·
·
·

·
·
·

·
·
·

·
·
·

·
·
·

45

7.363966079

7.037455184

103

7.288854606

7.037408966

46

7.358192526

7.037454388

104

7.222977769

7.03740817

47

7.218073116

7.037453591

105

7.0692883

7.037407373

48

7.15520363

7.037452794

106

7.062936083

7.037406576

49

7.134668063

7.037451997

107

7.05716253

7.037405779

50

6.998258493

7.0374512

108

6.984901697

7.037404982

i

− log P(i)

1

15.65355977

2

− log

α
n−i+1

Table A.4: FDR Method Applied to All Chromosomes Using Armitage Trend Test: Score 2
One-Sided Alternative

i

− log P(i)

Two-Sided Alternative

− log ni q ∗

i

− log P(i)

− log ni q ∗

1

15.65355977

7.037490243

1

15.95458977

7.037490243

2

15.65355977

6.736460247

2

15.65355977

6.736460247

3

15.25561977

6.560368988

3

15.47746852

6.560368988

4

15.17643852

6.435430252

4

15.47746852

6.435430252

5

15.10949173

6.338520239

5

15.47746852

6.338520239

·
·
·

·
·
·

·
·
·

·
·
·

·
·
·

·
·
·

193

4.762563575

4.751932934

205

4.779919099

4.725736382

194

4.762431027

4.749688513

206

4.744296879

4.723623023

195

4.761208396

4.747455632

207

4.728191006

4.721519897

196

4.752455696

4.745234172

208

4.727199986

4.719426908

197

4.748502961

4.743024017

209

4.727158648

4.717343957

198

4.740603973

4.740825053

210

4.705387958

4.715270948
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Table A.5: SRB Method Applied to All Chromosomes Using Armitage Trend Test: Score 3
One-Sided Alternative

Two-Sided Alternative

i

− log P(i)

α
− log n−i+1

7.037490243

1

15.95458977

7.037490243

15.95458977

7.037489446

2

15.95458977

7.037489446

3

15.95458977

7.037488649

3

15.95458977

7.037488649

4

15.95458977

7.037487853

4

15.95458977

7.037487853

5

15.65355977

7.037487056

5

15.95458977

7.037487056

·
·
·

·
·
·

·
·
·

·
·
·

·
·
·

·
·
·

82

7.172270273

7.037425701

381

7.060629554

7.037187371

83

7.16350943

7.037424904

382

7.059987948

7.037186574

84

7.158937026

7.037424107

383

7.057190494

7.037185776

85

7.086642167

7.03742331

384

7.053331656

7.037184979

86

7.039949146

7.037422514

385

7.048459333

7.037184182

87

7.035507398

7.037421717

386

7.026866128

7.037183384

i

− log P(i)

1

15.95458977

2

− log

α
n−i+1

Table A.6: FDR Method Applied to All Chromosomes Using Armitage Trend Test: Score 3
One-Sided Alternative

Two-Sided Alternative

i

− log P(i)

− log ni q ∗

7.037490243

1

15.95458977

7.037490243

15.95458977

6.736460247

2

15.95458977

6.736460247

3

15.95458977

6.560368988

3

15.95458977

6.560368988

4

15.95458977

6.435430252

4

15.95458977

6.435430252

5

15.65355977

6.338520239

5

15.95458977

6.338520239

·
·
·

·
·
·

·
·
·

·
·
·

·
·
·

·
·
·

207

4.766319169

4.721519897

1811

3.780647366

3.779571793

208

4.746166609

4.719426908

1812

3.780436936

3.77933205

209

4.73330389

4.717343957

1813

3.780397869

3.779092439

210

4.727998954

4.715270948

1814

3.780043274

3.77885296

211

4.721933118

4.713207788

1815

3.778860012

3.778613614

212

4.710493483

4.711154382

1816

3.776151949

3.778374399

i

− log P(i)

1

15.95458977

2

− log

i ∗
q
n
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APPENDIX B
GRAPHS OF LOD SCORES FOR SNPs
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Figure B.1: Chromosome 1: One and Two Sided

Figure B.2: Chromosome 2: One and Two Sided
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Figure B.3: Chromosome 3: One and Two Sided

Figure B.4: Chromosome 4: One and Two Sided
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Figure B.5: Chromosome 5: One and Two Sided

Figure B.6: Chromosome 6: One and Two Sided
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Figure B.7: Chromosome 7: One and Two Sided

Figure B.8: Chromosome 8: One and Two Sided
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Figure B.9: Chromosome 9: One and Two Sided

Figure B.10: Chromosome 10: One and Two Sided
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Figure B.11: Chromosome 11: One and Two Sided

Figure B.12: Chromosome 12: One and Two Sided
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Figure B.13: Chromosome 13: One and Two Sided

Figure B.14: Chromosome 14: One and Two Sided
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Figure B.15: Chromosome 15: One and Two Sided

Figure B.16: Chromosome 16: One and Two Sided
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Figure B.17: Chromosome 17: One and Two Sided

Figure B.18: Chromosome 18: One and Two Sided
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Figure B.19: Chromosome 19: One and Two Sided

Figure B.20: Chromosome 20: One and Two Sided
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Figure B.21: Chromosome 21: One and Two Sided

Figure B.22: Chromosome 22: One and Two Sided

